0001209191-23-037015.txt : 20230614
0001209191-23-037015.hdr.sgml : 20230614
20230614162124
ACCESSION NUMBER: 0001209191-23-037015
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230612
FILED AS OF DATE: 20230614
DATE AS OF CHANGE: 20230614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Coelho Mary Theresa
CENTRAL INDEX KEY: 0001720772
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38716
FILM NUMBER: 231014392
MAIL ADDRESS:
STREET 1: 52 SUNRISE PARK ROAD
CITY: NEW HAMPTON
STATE: NY
ZIP: 43017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gamida Cell Ltd.
CENTRAL INDEX KEY: 0001600847
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 NAHUM HAFZADI STREET
CITY: JERUSALEM
STATE: L3
ZIP: 95484
BUSINESS PHONE: 97226595666
MAIL ADDRESS:
STREET 1: 5 NAHUM HAFZADI STREET
CITY: JERUSALEM
STATE: L3
ZIP: 95484
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-12
0
0001600847
Gamida Cell Ltd.
GMDA
0001720772
Coelho Mary Theresa
C/O GAMIDA CELL LTD.
116 HUNTINGTON AVENUE
BOSTON
MA
02116
0
1
0
0
Chief Financial Officer
0
Share Option (Right to Buy)
1.98
2023-06-12
4
A
0
10000
0.00
A
2033-06-11
Ordinary Shares
10000
10000
D
This option vests on the earlier of (i) the date of the closing of a Merger/Sale (as such term is defined under the Issuer's 2017 Share Incentive Plan (as amended)), or (ii) May 22, 2024, so long as, prior to such date, (x) the Reporting Person has not terminated without cause the Reporting Person's Consulting Agreement (the "Agreement") with the Issuer or (y) the Issuer has not terminated the Agreement for breach (and such breach has not been cured).
/s/ Joshua F. Patterson, Attorney-in-Fact
2023-06-14